Is tocilizumah, a costly drug, really effective or just a drug to control IL6?

IL-6 inhibitor, tocilizumab (Actemra), is included as a standard of care in hospitalized adult patients with severe COVID-19 pneumonia. It cost 40,000 rs in india.

30 August 2020 8,719 17 View